United States · FDA National Drug Code directory
Memantine and Donepezil Hydrochlorides Extended-release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69238-1248_acd577e1-312c-4d5a-85b5-bc50ef9de545
- Product NDC
- 69238-1248
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Memantine and Donepezil
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170201
- Source listing expiry
- 20261231
Source-listed ingredients
- MEMANTINE HYDROCHLORIDE — 14 mg/1
- DONEPEZIL HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1248-3) · 69238-1248-3
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1248-9) · 69238-1248-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →